key: cord-0302297-jd5l8l4m authors: Baquero, F.; Campos, M.; Sempere, J.-M.; Galan, J.-C.; Moya, A.; Llorens, C.; de-los-Angeles, C.; Baquero-Artigao, F.; Canton, R. title: Simulating the impact of non-pharmaceutical interventions limiting transmission in COVID-19 epidemics using a membrane computing model date: 2021-07-06 journal: nan DOI: 10.1101/2021.07.01.21259828 sha: 487c8f0d28b315faa76b2bcb3b7ef7d423cb03df doc_id: 302297 cord_uid: jd5l8l4m Epidemics caused by microbial organisms are part of the natural phenomena of increasing biological complexity. The heterogeneity and constant variability of hosts, in terms of age, immunological status, family structure, lifestyle, work activities, social and leisure habits, daily division of time, and other demographic characteristics make it extremely difficult to predict the evolution of epidemics. Such prediction is, however, critical for implementing intervention measures in due time and with appropriate intensity. General conclusions should be precluded, given that local parameters dominate the flow of local epidemics. Membrane computing models allows us to reproduce the objects (viruses, hosts) and their interactions (stochastic but also with defined probabilities) with an unprecedented level of detail. Our LOIMOS model helps reproduce the demographics and social aspects of a hypothetical town of 10,320 inhabitants in an average European country where COVID-19 is imported from the outside. The above-mentioned characteristics of hosts and their lifestyle are minutely considered. The dynamics of the epidemics are reproduced and include the effects on viral transmission of innate and acquired immunity at various ages. The model predicts the consequences of delaying the adoption of non-pharmaceutical interventions (between 15 and 45 days after the first reported cases) and the effect of those interventions on infection and mortality rates (reducing transmission by 20%, 50%, and 80%) in immunological response groups. The lockdown for the elderly population as a single intervention appears to be effective. This modelling exercise exemplifies the application of membrane computing for designing appropriate interventions in epidemic situations. Epidemics are based on an ensemble of transmission events among heterogeneous hosts; 70 in fact, epidemics are determined by the density and intensity of natural biological fluxes 71 among biological entities connected by complex networks that respond to a highly 72 variable ensemble of causes and forces (Baquero, 2017 , Baquero, 2018a . Membrane- CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint a particular object that interacts with other objects (hosts, represented by membranes) in 94 particular scenarios, according to a set of rules and having sensitivity to the frequencies 95 of interacting objects. 96 Changes in the scenarios, rules and frequencies, resulting from varying interventions, will 97 influence the density of viral-host interactions. These changes are easy to modify in the 98 model, thereby helping to predict the success of each particular intervention or different 99 simultaneous intervention. This task is extremely difficult to test in practice (Soltesz et 100 al., 2020) and requires advanced modelling tools. The model applied in this study has 101 significant plasticity; the data entered into this model can be derived from observations 102 of particular settings, such as hospitals, the community, long-term care centres, and 103 schools. 104 Our simulator (which is also appliable to other viral diseases) is named LOIMOS, from 105 the Ancient Greek λοιμός, meaning plague or pestilence but can refer to any deadly 106 infectious disorder. A user-friendly interface is being developed for LOIMOS and will be 107 freely available. Interested readers should contact our first author, Marcelino Campos 108 (mcampos@dsic.upv.es). The basic scenario 112 First, we start by modelling the dynamics of the epidemic in an isolated COVID-19-free 113 population composed of 10,320 healthy individuals (a number resulting from 114 demographic adjustments) not previously exposed to the causal agent of the infection. 115 After introducing an infected person from another community, three cases were detected 116 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint 6 in this community. To reflect the natural dynamics of epidemics, our parameters refer to 117 a "wild" model population where no protective measures are considered. 118 Next, we explored the effect of adopting transmission-decreasing interventions of varying 119 intensity and adopting different times from the onset of the epidemic to evaluate their 120 influence on the epidemiological dynamics. For simplicity's sake, this article does not 121 detail the particular interventions for reducing transmission; however, the model allows 122 each one of them to be considered, either alone or in combination. These interventions 123 might include 1) the use of surgical masks by the general population, 2) use of FFP2 124 masks by the general population, 3) the use of facial masks, 4) the use of autonomous 125 respirators in highly exposed health workers, 4) hand washing and disinfection, 5) 126 reduction of sputum formation in the elderly, 6) isolation of COVID-negative elderly 127 individuals at home and nursing care facilities (considered in the study), 7) complete 128 lockdown, i.e., significant limitation in leaving the house, travelling abroad or allowing 129 foreigners to enter the region, 8) partial lockdown, limiting group activities and requiring 130 physical distancing in shops, restaurants, and leisure activities, telework for a portion of 131 the population, and 9) early detection of individuals and contact surveillance for the 132 presence of COVID-19. Given that each of these interventions' accounts for a percentage 133 of the total reduction in transmission and that their application varies significantly among 134 sites, we decided for this first article to use a global percentage representing the sum of 135 such interventions when applied at different intensities. Parametric structure of the model. The numerical data should correspond to the local 137 data (at any hierarchical level, such as hospitals, towns, regions, nations). Occasionally, 138 the exact quantitative data are not available; therefore, the types of parameters applied 139 can be categorized as 1) assumed parameters, representing choices made a priori based 140 on existing knowledge and scientific literature; 2) measured parameters that will be 141 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. 2) Internal home workers start working at 08:00, 09:00, 10:00, 16:00, 17:00 or 18:00 181 (with 10% assigned to at each of these times). They have a option of outside activity (e.g., CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. These members are therefore in public spaces from 09:00 to 10:00, in the care home from 211 10:00 to 16:00 and back in the public spaces on their way home from 16:00 to 17:00. Population numbers. In the model, we consider a representative original sample, 213 consisting of an isolated community (we do not consider the introduction of foreigners, 214 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint but this will be presented in a forthcoming study) of 10,320 healthy individuals (a number CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint reaching the respiratory tract or indirectly through hand-respiratory tract (nose, mouth) 265 contact. There should be a "minimal propagulum" for viral loads, a threshold below which 266 no significant (permanent) transmission takes place (estimated at fewer than 20,000 267 copies/mL) (Bullard et al., 2020) . When crossing this threshold, there is a certain 268 probability for contagion, the rate at which an infected patient can transmit the virus to CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. Natural immune response and receptivity to contagion 312 Some of the individuals exposed to the virus do not develop symptoms, even when 313 lacking acquired immunity. This lack of symptoms could be due to the rapid elimination 314 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. First, there are those who acquired the virus, which can replicate until reaching 20% of 326 the maximal viral load. During this process, the innate immunity is triggered, causing the 327 viral load to decrease. An acquired immune response does not occur. These cases are 328 either asymptomatic or have very mild symptoms. This type is here designed as the 329 "efficient innate immunity/lacking acquired immunity/mild to no symptoms" (E-inn/L-330 acq/N) type. Second, there are those in whom the viruses are efficiently cleared by their 331 innate immunity but that cross the viral load threshold for triggering acquired immunity. In most cases, these hosts remain asymptomatic or have mild symptoms. This type is 333 designed as the "efficient innate immunity/normal acquired immunity/mild to no 334 symptoms" (E-inn/N-acq/N) type. Third, there are the hosts whose innate immunity is 335 insufficient for reducing the viral load, which increases accordingly and crosses the 336 threshold after which symptomatic infection occurs and acquired immunity is developed. This type is designed as the "inefficient innate immunity/normal acquired 338 immunity/Symptomatic" (I-inn/N-acq/S) type. Fourth, there are the hosts whose innate 339 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint immunity is insufficient to clear the virus, resulting in a symptomatic infection; however, 340 their acquired immune response is weak or slow. This type is designed here as the 341 "inefficient innate immunity/weak acquired immunity/Symptomatic" (I-inn/W-acq/S) 342 type. The E-inn/L-acq/N and I-inn/W-acq/S types can be reinfected after exposure with a 343 contagious host but will respond to the new challenge according to their specific response 344 pattern. Table 1 lists the estimated frequency of these populations per age group that were 345 used in our model. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint transmitters, in general those who, after being exposed to the virus, were able to clear the 355 infection by innate immunity and are expected to have a low or non-existent viral load. 356 We considered that these hosts have an average transmission rate of <0.01 per person/h. Non-symptomatic hosts that progress to a more severe status have a transmission rate of 358 0.02 person/h. Table 2 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint response, which can be weak (such as the during the first contagion) or more effective 378 than during the first contact. We consider both probabilities equivalent (50%-50%). Elderly lockdown 380 The "elderly lockdown" intervention involves cancelling all external visits to nursing 381 homes, closing elderly day centres, and reducing by 80% the external activities of the 382 elderly. globally but also differentiates the contagions originating from cases that progress to 406 healthy due to innate or acquired immunity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. In these symptomatic patients, the number able to develop a normal acquired immunity 425 (green line) decreases more rapidly but not excessively compared with those with weak is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. infection. I-inn/N-acq/S (symptomatic): insufficient innate immunity, normal acquired immunity 433 (green line); E-inn/N-acq/N (non-symptomatic): efficient innate immunity, with normal acquired 434 immunity (pink); E-inn/L-acq/N (non-symptomatic): efficient innate immunity, lacking or with 435 very weak acquired immunity due to poor antigenic challenge, violet; I-inn/N-acq (S, 436 symptomatic): insufficient innate immunity, weak acquired immunity (dark blue). Steps in the 437 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. prevalence is 42%-45% for non-symptomatic cases and 50%-58% for symptomatic 453 cases. Combining the early implementation of interventions and high intensity, 80% of 454 the reduction in transmission, the maximum prevalence values strongly decrease below 455 90% (90%-95% for non-symptomatic cases and 92%-95% for symptomatic cases). The differences between the initial implementations to decrease transmission at 15 or 23 457 days, for any level of intensity, are relatively minor. If these actions are promoted after 458 30 days, the effects in reducing maximal prevalence are maintained and remain modest 459 at 20% intensity. At a 50% intensity of reduction, we achieve lower reductions in 460 maximum prevalence after 30 days in transmission for non-symptomatic cases (32%-461 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint 22 35%) and symptomatic cases (38%-40%). Even at an 80% intensity of reduction, there is 462 a clear drop in the reduction of maximum prevalence (65%-79% for asymptomatic cases 463 and 79%-81% for symptomatic cases). If interventions are adopted at 37 days after the 464 onset of the epidemic, the reductions in maximum prevalence rates are relatively modest 465 compared with these obtained at 30 days for transmission reductions of 20% and 50%. Therefore, the early adoption of interventions (e.g., 15 days after the onset of the 502 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint epidemic) ensures that the effect is extended in time, influencing all stages in which 503 patients potentially worsen. This explains why an 80% reduction in transmission (grey 504 line) adopted at 15 days pushes the maximum prevalence peak of asymptomatic patients 505 from less than 50 days in the case of non-intervention to more than 100 days. However, 506 the same 80% reduction adopted at 45 days has much less effect on symptomatic patients, 507 because this late intervention has arrived too late to decrease the number of asymptomatic 508 patients and thus their potential progression to severity. Moreover, as the emergence of 509 severely ill patients is naturally delayed, the late adoption of interventions results in . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint We estimated the age-related mortality in the absence of interventions in our model as 545 follows: <0.1% for the 0-12-year group, 0.29% for the 13-19-year group, 1.64% for the 546 20-59-year group and 17.58% for >60-year group. Figure 5 shows the progression of Elderly lockdown 565 Considering the above results, we tested the effect of an "elderly lockdown" in the 566 absence of other general interventions. The "elderly lockdown" intervention implies 567 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint work and what they do at the weekend" (Adam, 2020) . Of course, the interactive 639 parameters are unknown or known imprecisely, but they can be established as ranges Infected-Recovered) and others, such as GitHub tools that analyse epidemiological 663 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint scenarios (Flaxman et al., 2020; Bhatt 2020; Stokes et al., 2020) . Our computational 664 model mimics the dynamics of a single community with a limited number or inhabitants 665 (approximately 10,000) and isolated from other sources of infection. This precludes us 666 from predicting the "global dynamics" of the infection and makes it difficult to compare 667 some of our results with other modelling estimates, but in general the differences are 668 weak. For instance, our predicted "mortality peak" in the absence of interventions occurs 669 earlier (a little more than 2 months) than in other model estimates (Ferguson et al., 2020) . 670 However, the model allows for a realistic prediction of the consequences of applying 671 interventions. The main results of this study (many other results can be obtained with the same model . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint The positive effect of an early lockdown for elderly patients as a single intervention on 689 the evolution of epidemics is clearly visible in our modelling. The role of the elderly in 690 epidemiological dynamics is recognized as the most important factor behind the major 691 COVID-19 outbreak (Melin et al, 2020) . A number of countries, such as Sweden, adopted 692 a de-facto herd immunity approach, without imposing severe limitations to viral 693 propagation in the community, with controversial results (Bjorklund and Ewing, 2020; 694 Claeson and Hanson, 2020). The goal of the Swedish Public Health Agency was to assure 695 the intensive care for elderly patients with the highest mortality risk (Chew et al., 2021) . 696 This approach could probably have been accompanied by a strict lockdown for the 697 elderly. Considering the European incidence of COVID-19 deaths in May 2021, Sweden 698 had a lower per capita incidence of COVID-19 mortality than France, Spain, United 699 Kingdom, Italy, Belgium, or Hungary (Steward, 2021), and elderly lockdown is probably 700 one of the most effective interventions to be considered (Soltesz et al., 2020) . 701 We should accept that the multifactorial and variable landscape of viral epidemics, where 702 the infection process itself modifies the transmission parameters, is also influenced by the 703 geography, demography, and lifestyles of the population, which makes it difficult to 704 establish general fixed parameters, to a certain extent leading to a "parametric 705 scepticism". Therefore, the use of flexible models, such as those applied in this study, can 706 mimic differing conditions (that can be adjusted to the locally observed conditions). Integrating parametric ranges and stochastic dynamics is simply a necessity in predicting 708 the policy of corrective interventions in a particular local landscape. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint MC and FB were sponsored by the Projects COV20_00067 of the Program SARS-COV-714 2 and COVID-19 infection of the Instituto de Salud Carlos III and the Regional Government of Madrid 717 (InGeMICS-B2017/BMD-3691). For JCG, this study was partially founded by the 718 Autonomous Community of Madrid, Spain (COVID-19 Grant, 2020) and the Ramón y 719 For AM, this study was 720 supported by grants from the Spanish Ministry of Science and Innovation 105969GB-I00), the government of Valencia (project Prometeo/2018/A/133) and co-722 financed by the European Regional Development Fund (ERDF) Modelling the pandemic: The simulations driving the world's response to 726 COVID-19 Commensal bacteria in the human intestine produce 728 compounds that inhibit SARS-CoV-2. World Microbe Forum Transmission as a basic process in microbial biology Causality in biological transmission: forces and energies A model of antibiotic resistance evolution 734 dynamics through P systems with active membranes and communication rules. In: 735 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Enjoying natural computing Estimating the effects of non-pharmaceutical interventions on COVID-19 in 738 It shouldn't be a 740 model for the rest of the world Rapid and sensitive detection of SARS-CoV-2 RNA 743 using the Simplexa™ COVID-19 direct assay Predicting infectious SARS-CoV-2 from diagnostic 745 samples Recomendaciones sobre el 747 manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo 748 de la Asociación Española de Pediatría (AEP) A membrane computing simulator of trans-750 hierarchical antibiotic resistance evolution dynamics in nested ecological compartments 751 (ARES) Simulating multilevel dynamics of antimicrobial 753 resistance in a membrane computing model Simulating the influence of conjugative 755 plasmids kinetic values on the multilevel dynamics of antimicrobial resistance in a 756 membrane computing model A dynamic model of COVID-19: contagion and implications National outcomes and characteristics of 760 patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort 761 study COVID-19 and the Swedish enigma. The Lancet 2021 Children account for a small proportion of 765 diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults Not just antibodies: B cells and T cells mediate immunity to 768 COVID-19 Innate immunity plays a key role in controlling viral load in COVID-771 19: mechanistic insights from a whole-body infection dynamics model Impact of non-pharmaceutical 773 interventions (NPIs) to reduce COVID19 mortality and healthcare demand Estimating the effects of non-pharmaceutical interventions on 776 COVID-19 in Europe Essential epidemiological parameters of COVID-19 for clinical and mathematical 779 modeling purposes: a rapid review and meta-analysis International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted The role of children in the transmission of SARS-CoV-2-19 -a rapid review Whose coronavirus strategy worked best? Scientists hunt most effective 783 policies Antibiotic resistance: time of synthesis 785 in a post-genomic age Clinical characteristics of coronavirus disease A systematic review of antibody 789 mediated immunity to coronaviruses: kinetics, correlates of protection, and association 790 with severity IHME COVID-19 Forecasting Team. Modeling COVID-19 scenarios for the United 792 States Shedding of infectious virus in hospitalized 794 patients with coronavirus disease-2019 (COVID-19): duration and key determinants Critical role of neutralizing antibody for SARS-CoV-2 797 reinfection and transmission Development of child immunity in the context of 799 COVID-19 pandemic the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted COVID-19 Transmission and children: the child is not to blame Clinical course and molecular viral shedding among 806 symptomatic and symptomatic patients with SARS-CoV-2 infection in a community 807 treatment center in the Republic of Korea The Corona Commission. Elderly care 809 during the pandemic. Ministry of Health and Social Affairs, summary of SOU 2020:80 Age-specific mortality and immunity 814 patterns of SARS-CoV-2 Dynamic panel estimate-based health 816 surveillance of SARS-CoV-2 infection rates to inform public health policy: model 817 development and validation Salomaa A (eds). The Oxford Handbook of Membrane Computing Complexity classes in 821 models of cellular computing with membranes. Natural Comput Nudges against pandemics: Sweden's COVID-19 containment strategy in 823 perspective COVID-19 in children and the dynamics 825 of infection in families International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted SARS-CoV-2: a time for clear and immediate action SARS-CoV-2 viral load predicts COVID-19 829 mortality Duration of infectiousness and correlation 831 with RT-PCR cycle threshold values in cases of COVID-19 The effect of interventions on COVID-834 19 Modelling the pandemic Incidence of coronavirus (COVID-19) deaths in the EEA and the UK 2021 The relative effects of non-pharmaceutical 840 interventions on early COVID-19 mortality: natural experiment in 130 841 countries. medRxiv Temporal profiles of viral load in posterior 843 oropharyngeal saliva samples and serum antibody responses during infection by SARS-844 CoV-2: an observational cohort study . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.01.21259828 doi: medRxiv preprint